Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Lung Denervation (TLD) With the Ryme Medical Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Ryme Medical TLD Pilot Study

NCT05967091 is registered in ClinicalTrials.gov with Ryme Medical, Inc. as lead sponsor.

NCT NCT05967091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05967091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Lung Denervation (TLD) With the Ryme Medical Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Ryme Medical TLD Pilot Study
Lead sponsor
Ryme Medical, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 6, 2024
Completion date
May 31, 2026
Enrollment
60 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease